SCHEMBL4865720

SCHEMBL4865720

CCCCC1=CC(=O)CCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 4/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP19A1 P11511 1/20 0.33
HSD17B10 Q99714 1/20 0.32
DDB1 Q16531 2/20 0.32
CRBN Q96SW2 2/20 0.32
PTGS2 P35354 2/20 0.32
CA2 P00918 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ACHE P22303 1/20 0.32
BACE1 P56817 1/20 0.32
DAO P14920 1/20 0.32
MAPT P10636 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4869101 0.96 MAPT (0.35) ALOX5ALDH1A1HPGDKDM4ECYP1A2
SCHEMBL3505646 0.90 GPR84 (0.40) ALOX5PTGS2ACHEBACE1KMT2A
SCHEMBL6282240 0.89 GPR84 (0.42) ALOX5PTGS2ACHEBACE1
SCHEMBL1022486 0.88 ALOX5 (0.36) ALOX5CYP19A1PTGS2ACHEBACE1
SCHEMBL3936524 0.83 MAPT (0.38) ALDH1A1CYP19A1MAPTMEN1KMT2A
SCHEMBL1021982 0.82 ACHE (0.40) ALOX5PTGS2ACHEBACE1
SCHEMBL4867436 0.80 ACHE (0.43) ALOX5PTGS2ACHEBACE1
SCHEMBL276375 0.79 SIGMAR1 (0.34) KDM4EMEN1KMT2A
SCHEMBL29165332 0.79 NOS3 (0.38) ALDH1A1MAPTMEN1KMT2A
SCHEMBL8556779 0.74 NOS1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080125310-A1 Hydride reduction of alpha, beta-unsaturated carbonyl compounds using chiral organic catalysts CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2008-05-29 US disclosed
US-7323604-B2 Hydride reduction of α,β-unsaturated carbonyl compounds using chiral organic catalysts CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2008-01-29 US disclosed
US-20060161024-A1 Hydride reduction of alpha, beta-unsaturated carbonyl compounds using chiral organic catalysts CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060161024-A1 Hydride reduction of alpha, beta-unsaturated carbonyl compounds using chiral organic catalysts ECH1, CBR1, DHCR24 ALOX5 376/4885ALDH1A1 14/4885HPGD 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.